Irbesartan
- Product NDC
- 72603-672
- 11-digit product format
- 726030672
- Labeler code
- 72603
- Product ID
- 72603-672_08c85ada-de6f-4cff-bc81-2332a22bef45
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Irbesartan
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NorthStar RxLLC
- Application
- ANDA202254
- Marketing category
- ANDA
- Marketing start
- 2026-03-25
- Substance
- IRBESARTAN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Irbesartan
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| IRBESARTAN | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | J0E2756Z7N |
| Rxcui | 200094, 200095, 200096 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72603-672-01 | Irbesartan | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
| 72603-672-02 | Irbesartan | 90 in 1 BOTTLE | TABLET | 90 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72603-672-01 | 72603067201 | 30 TABLET in 1 BOTTLE (72603-672-01) | 30 tablet | 2026-03-25 | No | No | Historical |
| 72603-672-02 | 72603067202 | 90 TABLET in 1 BOTTLE (72603-672-02) | 90 tablet | 2026-03-25 | No | No | Historical |